Foundation Medicine BioPharma Solutions

UniquelyFMI

FoundationOne®

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. 

For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter. 

Community Guidelines: bit.ly/FMICommunityGuidelines

Google Ventures

Kleiner Perkins

Third Rock Ventures

Redmile Group

Deerfield Capital Management

Casdin Capital

Roche Venture Fund

Bill Gates

Evan Jones

Foundation Medicine

Foundation Medicine is a lead sponsor at this year’s 8th Annual Liquid Biopsy for Precision Oncology Summit! Looking forward to joining industry leaders to discuss how we are partnering and driving innovation in liquid biopsy and ctDNA monitoring. Don’t miss our plenary presentation, hosted workshop, and networking reception. Click the link to learn more and schedule a meeting: https://bit.ly/3uGDWTC

"Anyone with lungs can get lung cancer.” As a lung cancer survivor, physician, Dr. Sydney Barned advocates for more #awareness and empathy surrounding #lungcancer. Learn how Sydney and other oncology experts are setting the standard for research and treatment options: https://bit.ly/42D3AoP

Meet Tristen, our Senior Scientist in Assay Development. Her childhood fascination with forensic novels led her down a career path that unfolded in its own captivating narrative — an inspirational story of unexpected connections that shaped her journey. Read Tristen’s blog to hear more about the experiences that brought her to Foundation Medicine and her personal connection to our mission: https://bit.ly/3ut2QGb 

#WeAreFMI 

#ICYMI, Foundation Medicine’s Dr. Takara Scott led oncology leaders from LUNGevity Foundation and Moffitt Cancer Center in a discussion on the latest research and initiatives to help combat the disparities #lungcancer patients face today. During the event, panelists highlighted how important it is to ensure that the #innovation and #progress being made in lung cancer diagnostics are accessible to all patients. Watch the full Disparities in Lung Cancer event discussion here: https://lnkd.in/eUmkfer9

Foundation Medicine, Inc. develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.

COM:FOUNDATIONMEDICINE

Foundation Medicine, Inc.

Filings Not Available